Last reviewed · How we verify
NCT04874792: COVID-19
Clinical Characteristics of Deceased With COVID-19
trial in Covid19 in 282 participants. Completed in 31 December 2020.
30 November 2020
Quick facts
| Lead sponsor | Dhaka Medical College |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 282 |
| Start date | 1 July 2020 |
| Primary completion | 30 November 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Bangladesh |
Conditions studied
- Covid19 — all drugs for Covid19 →
Sponsor
Dhaka Medical College
Who can join
14 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to describe the clinical characteristics of patients who died from COVID-19 in the largest hospital in Bangladesh to understand the risk associated with COVID-19 related mortality in this region. This is a retrospective study where a review of hospital records of patients will be done who died from COVID-19 in Dhaka Medical College Hospital from 3rd May to 31 August 2020. All available demographic, clinical, laboratory information, radiological feature, and patients' management will be retrieved from the record section to be analyzed and described.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04874792
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Dhaka Medical College trials
Trials by the same sponsor.
- NCT07381426 — Ferric Citrate in Iron Deficiency Anemia During Pregnancy · Phase 3 · not yet recruiting
- NCT06938659 — Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients · Phase 2, PHASE3 · not yet recruiting
- NCT04527562 — Colchicine in Moderate Symptomatic COVID-19 Patients · NA · completed
- NCT04523831 — Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04874792 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dhaka Medical College
- Last refreshed: 6 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04874792.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing